Skip to Content

Ipilimumab

In the US, Ipilimumab (ipilimumab systemic) is a member of the drug class anti-CTLA-4 monoclonal antibodies and is used to treat Melanoma and Melanoma - Metastatic.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC11

CAS registry number (Chemical Abstracts Service)

0477202-00-9

Chemical Formula

C6472-H9972-N1732-O2004-S40

Therapeutic Categories

Antineoplastic agent

Immunomodulator

Anti-CTLA-4 monoclonal antibody

Chemical Name

Immunogloblulin G1, anti-(human CTLA-4 (antigen)) (human Ý1-chain), disulfide with human kappa-chain, dimer (WHO )

Foreign Names

  • Ipilimumabum (Latin)
  • Ipilimumab (German)
  • Ipilimumab (French)
  • Ipilimumab (Spanish)

Generic Names

  • Ipilimumab (OS: USAN, BAN)
  • BMS 734016 (IS)
  • MDX-010 (IS)
  • MDX-CTLA-4 (IS)
  • UNII-6T8C155666 (IS)

Brand Names

  • Yervoy
    Bristol Myers Squibb, Chile; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, United States; Bristol-Myers Squibb Pharmaceutical, United Kingdom; Bristol-Myers Squibb Pharmaceuticals, Austria; PharmaSwiss, Croatia (Hrvatska); Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Sweden

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide